Skip to main content
Sunday
September 01, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
বাংলা
SUNDAY,
SEPTEMBER 01, 2024
AstraZeneca's vaccine
Coronavirus chronicle
Sri Lanka reports six cases of blood clots among AstraZeneca vaccine recipients, 3 dead
Analysis
Missteps could mar long-term credibility of AstraZeneca shot
Coronavirus chronicle
AstraZeneca may have provided incomplete efficacy data from latest Covid-19 trial: NIAID
Coronavirus chronicle
AstraZeneca vaccine 79% effective in US trial
Coronavirus chronicle
No clotting case in India after Oxford dose
Coronavirus chronicle
WHO insists AstraZeneca vaccine safe as jab faces new setbacks
Coronavirus chronicle
AstraZeneca to miss second-quarter EU vaccine supply target by half
Coronavirus chronicle
Mexico gets AstraZeneca doses from India, expects more Pfizer
Coronavirus chronicle
South Africa may sell AstraZeneca shots as it switches to J&J vaccine to fight variant
Coronavirus chronicle
AstraZeneca vaccine could get WHO emergency approval by mid-February
Coronavirus chronicle
Global health officials back AstraZeneca vaccine after South Africa study rings alarm
Coronavirus chronicle
UK says Astrazeneca vaccine prevents Covid-19 death as South Africa halts shots
Coronavirus chronicle
Oxford/AstraZeneca Covid shot less effective against South African variant: Study
Show More